The Value of Follow-On Biopharma Innovation for Health Outcomes and Economic Growth

Not all pharmaceutical breakthroughs are brand-new molecules—some of the most impactful innovations are the ones that refine what already exists. Follow-on biopharma innovations enhance existing therapies by improving safety, tailoring treatments to specific populations, and making medications easier to use—leading to better patient outcomes and lower health-care costs. These developments can also drive economic growth by reducing absenteeism and encouraging healthier, more productive populations. Policies like the Orphan Drug Act and Best Pharmaceuticals for Children Act have proven crucial in supporting this kind of life-improving innovation.